Novelion Therapeutics Inc. (NVLN:NASDAQ) Investor Relations Material

Overview

Novelion Therapeutics is a biopharmaceutical company that aims to improve the lives of individuals with rare diseases by developing new standards of care. The company focuses on advancing its portfolio of rare disease therapies through investing in science and clinical development.

Annual Reports

Frequently Asked Questions

What is Novelion Therapeutics Inc.'s ticker?

Novelion Therapeutics Inc.'s ticker is NVLN

What exchange is Novelion Therapeutics Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Novelion Therapeutics Inc.'s headquarters?

They are based in Vancouver, British Columbia

How many employees does Novelion Therapeutics Inc. have?

There are 201-500 employees working at Novelion Therapeutics Inc.

What is Novelion Therapeutics Inc.'s website?

It is http://www.novelion.com/

What type of sector is Novelion Therapeutics Inc.?

Novelion Therapeutics Inc. is in the Healthcare sector

What type of industry is Novelion Therapeutics Inc.?

Novelion Therapeutics Inc. is in the Biotechnology industry

Who are Novelion Therapeutics Inc.'s peers and competitors?

The following five companies are Novelion Therapeutics Inc.'s industry peers:

- Voyager Therapeutics Inc

- Genocea Biosciences Inc

- 89Bio

- Nuformix plc

- Pulmatrix, Inc.